These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24712323)

  • 1. Prevalence and clinical relevance of the morphological substrate of ventricular arrhythmias in patients without known cardiac conditions detected by cardiovascular MR.
    Weisser-Thomas J; Ferrari VA; Lakghomi A; Lickfett LM; Nickenig G; Schild HH; Thomas D
    Br J Radiol; 2014 Jun; 87(1038):20140059. PubMed ID: 24712323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy.
    Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS
    Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
    Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening young athletes for diseases at risk of sudden cardiac death: role of stress testing for ventricular arrhythmias.
    Zorzi A; Vessella T; De Lazzari M; Cipriani A; Menegon V; Sarto G; Spagnol R; Merlo L; Pegoraro C; Marra MP; Corrado D; Sarto P
    Eur J Prev Cardiol; 2020 Feb; 27(3):311-320. PubMed ID: 31791144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A preliminary study on the relationship between idiopathic arrhythmia and cardiac magnetic resonance imaging defined cardiac features in patients with straight back syndrome].
    Chen L; Ma XH; Zhao L; Bai R; Li SN; Wang L; Chen H; Fan ZM; Lou MW; Niu YD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Nov; 45(11):948-953. PubMed ID: 29166721
    [No Abstract]   [Full Text] [Related]  

  • 6. Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation.
    Andreu D; Ortiz-Pérez JT; Boussy T; Fernández-Armenta J; de Caralt TM; Perea RJ; Prat-González S; Mont L; Brugada J; Berruezo A
    Eur Heart J; 2014 May; 35(20):1316-26. PubMed ID: 24394378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conduction defects/cardiomyopathies.
    Gilbert-Barness E
    Adv Pediatr; 2014 Aug; 61(1):127-48. PubMed ID: 25037126
    [No Abstract]   [Full Text] [Related]  

  • 8. CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography.
    Andreini D; Dello Russo A; Pontone G; Mushtaq S; Conte E; Perchinunno M; Guglielmo M; Coutinho Santos A; Magatelli M; Baggiano A; Zanchi S; Melotti E; Fusini L; Gripari P; Casella M; Carbucicchio C; Riva S; Fassini G; Li Piani L; Fiorentini C; Bartorelli AL; Tondo C; Pepi M
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):410-421. PubMed ID: 31326488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis.
    Boldrini M; Salinaro F; Mussinelli R; Raimondi A; Alogna A; Musca F; Palladini G; Merlini G; Perlini S
    Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):327-35. PubMed ID: 23879272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Cardiac Magnetic Resonance Imaging in Patients with Idiopathic Ventricular Arrhythmias.
    Muser D; Santangeli P; Selvanayagam JB; Nucifora G
    Curr Cardiol Rev; 2019; 15(1):12-23. PubMed ID: 30251607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 12-Lead electrocardiogram as a predictor of sudden cardiac death: from epidemiology to clinical practice.
    Eranti A; Aro AL; Kenttä T; Holkeri A; Tikkanen JT; Junttila MJ; Huikuri HV
    Scand Cardiovasc J; 2016; 50(5-6):253-259. PubMed ID: 27454252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECG abnormalities in myopathies, coronary heart disease and controls.
    Finsterer J; Stöllberger C; Köcher K; Mamoli B
    Herz; 1997 Oct; 22(5):277-82. PubMed ID: 9360915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients.
    Zhang J; Sacher F; Hoffmayer K; O'Hara T; Strom M; Cuculich P; Silva J; Cooper D; Faddis M; Hocini M; Haïssaguerre M; Scheinman M; Rudy Y
    Circulation; 2015 Jun; 131(22):1950-9. PubMed ID: 25810336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac arrythmias: multimodal assessment integrating body surface ECG mapping into cardiac imaging.
    Cochet H; Dubois R; Sacher F; Derval N; Sermesant M; Hocini M; Montaudon M; Haïssaguerre M; Laurent F; Jaïs P
    Radiology; 2014 Apr; 271(1):239-47. PubMed ID: 24475841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of ventricular arrhythmias at exercise testing for prediction of non-ischaemic left ventricular scar in athletes.
    Brunetti G; Graziano F; Cavigli L; Cipriani A; D'Ascenzi F; Bauce B; Pilichou K; Perazzolo Marra M; Corrado D; Zorzi A
    Eur J Prev Cardiol; 2023 Jan; 30(2):107-116. PubMed ID: 36166397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging.
    Veltmann C; Papavassiliu T; Konrad T; Doesch C; Kuschyk J; Streitner F; Haghi D; Michaely HJ; Schoenberg SO; Borggrefe M; Wolpert C; Schimpf R
    Heart Rhythm; 2012 Mar; 9(3):414-21. PubMed ID: 22119454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
    Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of T-wave peak to T-wave end interval in identifying malignant arrhythmias in patients with Chagas disease.
    Armaganijan L; Moreira DA; Nolasco de Araújo RR; Puzzi MA; Munhoz FP; Carvalho MJ; Gallo LN; França JI; Lopes RD
    Hellenic J Cardiol; 2013; 54(6):429-34. PubMed ID: 24305578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of CMR and PET in Predicting Ventricular Arrhythmias in Ischemic Cardiomyopathy Patients Eligible for ICD.
    Rijnierse MT; van der Lingen ACJ; de Haan S; Becker MAJ; Harms HJ; Huisman MC; Lammertsma AA; van de Ven PM; van Rossum AC; Knaapen P; Allaart CP
    JACC Cardiovasc Imaging; 2020 Aug; 13(8):1755-1766. PubMed ID: 32305468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
    Rijnierse MT; de Haan S; Harms HJ; Robbers LF; Wu L; Danad I; Beek AM; Heymans MW; van Rossum AC; Lammertsma AA; Allaart CP; Knaapen P
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):20-30. PubMed ID: 24343851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.